Most diseases today have stopped responding to general treatment. This is because only few group of persons are used during clinical trials and because of lack of big genomic data, during this trials, it has become hard to know who will respond to a certain treatment and who won't. Genomic data's, can be used to know which patients are likely to respond to a given treatment. This will allow for the availability of more effective and quick treatment. If treatment can be based on genomes, most rare diseases will be treated. This is solely because these diseases will be treated based on individual levels as genetics will be taken into considerations and drugs developed and prescribed.
Shivom offers the first ever integrated solution for patients and genome data donors where everybody will be able to have their genome sequenced and securely stored. With this, the best course of cure for patients with a particular condition will be identified. There will also be prevention of disease in healthy individuals and prediction of disease risk. Diseases will be diagnosed, treatment, including choice of most effective medication and dosage will be made available. Disease prognosis and identifying of new drug targets will also be made possible.
The future treatment of over 7000 disease as seen today, will be based on genomic data's. This is because using genomic data to analyse a given health issue will enable the medical practitioner know which prescription to give and which to avoid. Because healthcare data in some regions are centralized and managed by only the health officials and government, individuals do not have an access to the data and it's management. Shivom will be leveraging on the blockchain to create an open marketplace for healthcare providers to add their apps and services, alongside genomic data analytics and personalized medicine and also donors to be able to protect their data and get paid before any organisation can have access to its use.
The Shivom ecosystem will transform genomic data into useable information and also break down data silos, help accelerate clinical trials, facilitate drug research and development and sponsor sequencing projects to get access to relevant data. Shivom wants to create a platform where donors can sell their genetic data to merchandise that need them. They're providing an opportunity for each user to sell or share their DNA data for global study.
SHIVOM TOKENS.
The Shivom tokens will be known with the ticker Omix. OmiX token is a key component that enables buying, trading, incentivize and other services on the Shivom ecosystem. Omix tokens gives one the following advantages :
• Ability to acquire premium services in the Shivom ecosystem
• Ability to acquire genome sequencing kits
• Ability to sponsor sequencing projects
• Ability to acquire access to health/fitness apps from 3rd party
providers
• Ability to access the genome database
• Ability to pay donors for data/participation in research studies
• Ability for service providers to use the platform.
The total number of Omix tokens is 3billion. 990 Omix tokens will be sold during the tokensale.
For further enquiries
Website: www.shivom.io
Twitter: http://twitter.com/projectshivom
Telegram : https://t.me/projshivom
LinkedIN : http://linkedin.com/company/18302733/
Ann Thread: https://bitcointalk.org/index.php?topic=2365709
Whitepaper: https://shivom.io/files/Shivom-Executive-Summary.pdf
Medium : http://medium.com/@projectshivom
I can be reached on bitcointalk.org : https://bitcointalk.org/index.php?action=profile;u=1016770
Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!
If you enjoyed what you read here, create your account today and start earning FREE STEEM!